Cardiac Autonomic Neuropathy in the Diabetic Patient: Does ^sup 123^I-MIBG Imaging Have a Role to Play in Early Diagnosis?
Cardiac Autonomic Neuropathy in the Diabetic Patient: Does ^sup 123^I-MIBG Imaging Have a Role to Play in Early Diagnosis?
encyclopedia.com
From: Journal of Nuclear Medicine Technology | Date: June 1, 2004| Author: Scott, Lynda A; Kench, Peter L | Copyright Society of Nuclear Medicine Jun 2004. Provided by ProQuest LLC.
Objectives: In diabetes, extended adrenergic receptor stimulation with hyperglycemia and insulin deficiency is associated with cardiac autonomic dysfunction. Clinically evident diabetic cardiac autonomic neuropathy (CAN) is associated with a poor prognosis. Research studies indicate that autonomic function tests, which are traditionally used to diagnose diabetic CAN, are less sensitive than ^sup 123^I-metaiodobenzylguanidine (MIBG) imaging, particularly in the early stages of the disease. This established imaging technique makes use of the noradrenaline analog MIBG, which is radiolabeled with ...
Read all of this article with a FREE trial to HighBeam Research
HighBeam™ Research, Inc. © Copyright 2009. All rights reserved.